Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of JAGSON PHAR. For more details, see the JAGSON PHAR quarterly results and JAGSON PHAR share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.9 |
No. of shares | m | 26.44 |
1 Week | % | 7.2 |
1 Month | % | 11.1 |
1 Year | % | -7.8 |
52 week H/L | Rs | 513.9/270.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
JAGSON PHAR EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 35 | 32 | 102 | 314 | 420 | |
Low | Rs | 22 | 16 | 17 | 75 | 254 | |
Sales per share (Unadj.) | Rs | 63.7 | 60.5 | 71.7 | 83.0 | 90.3 | |
Earnings per share (Unadj.) | Rs | 2.8 | 3.0 | 6.5 | 7.2 | 10.2 | |
Diluted earnings per share | Rs | 2.7 | 3.0 | 6.5 | 7.1 | 10.1 | |
Cash flow per share (Unadj.) | Rs | 3.1 | 3.4 | 6.9 | 7.8 | 10.7 | |
Dividends per share (Unadj.) | Rs | 0.25 | 0.50 | 1.00 | 4.00 | 5.00 | |
Adj. dividends per share | Rs | 0.25 | 0.50 | 0.99 | 3.96 | 4.96 | |
Avg Dividend yield | % | 0.9 | 2.1 | 1.7 | 2.1 | 1.5 | |
Book value per share (Unadj.) | Rs | 39.9 | 42.4 | 46.5 | 50.7 | 57.3 | |
Adj. book value per share | Rs | 39.5 | 42.0 | 46.1 | 50.2 | 56.8 | |
Shares outstanding (eoy) | m | 26.20 | 26.20 | 26.20 | 26.20 | 26.20 | |
Price / Sales ratio | x | 0.4 | 0.4 | 0.8 | 2.3 | 3.7 | |
Avg P/E ratio | x | 10.4 | 8.0 | 9.1 | 27.0 | 33.1 | |
P/CF ratio (eoy) | x | 9.1 | 7.0 | 8.6 | 25.0 | 31.6 | |
Price / Book Value ratio | x | 0.7 | 0.6 | 1.3 | 3.8 | 5.9 | |
Dividend payout | % | 9.1 | 16.6 | 15.4 | 55.6 | 49.0 | |
Avg Mkt Cap | Rs m | 749 | 630 | 1,552 | 5,090 | 8,831 | |
Total wages/salary | Rs m | 466 | 504 | 540 | 577 | 652 |
JAGSON PHAR INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,668 | 1,586 | 1,879 | 2,176 | 2,367 | |
Other income | Rs m | 14 | 25 | 44 | 34 | 57 | |
Total revenues | Rs m | 1,683 | 1,611 | 1,923 | 2,210 | 2,424 | |
Gross profit | Rs m | 93 | 85 | 191 | 250 | 307 | |
Depreciation | Rs m | 10 | 11 | 11 | 15 | 12 | |
Interest | Rs m | 7 | 5 | 5 | 3 | 4 | |
Profit before tax | Rs m | 90 | 94 | 219 | 266 | 348 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 18 | 15 | 48 | 78 | 81 | |
Profit after tax | Rs m | 72 | 79 | 171 | 189 | 267 | |
Gross profit margin | % | 5.6 | 5.4 | 10.2 | 11.5 | 13.0 | |
Effective tax rate | % | 19.8 | 16.4 | 22.0 | 29.2 | 23.2 | |
Net profit margin | % | 4.3 | 5.0 | 9.1 | 8.7 | 11.3 |
JAGSON PHAR BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 976 | 963 | 1,205 | 1,163 | 1,722 | |
Current liabilities | Rs m | 282 | 346 | 404 | 341 | 352 | |
Net working cap to sales | % | 41.6 | 38.9 | 42.6 | 37.7 | 57.9 | |
Current ratio | x | 3.5 | 2.8 | 3.0 | 3.4 | 4.9 | |
Inventory Days | Days | 28 | 60 | 41 | 91 | 9 | |
Debtors Days | Days | 454 | 494 | 246 | 26 | 32 | |
Net fixed assets | Rs m | 382 | 524 | 437 | 551 | 304 | |
Share capital | Rs m | 131 | 131 | 131 | 131 | 131 | |
"Free" reserves | Rs m | 914 | 979 | 1,088 | 1,197 | 1,370 | |
Net worth | Rs m | 1,045 | 1,110 | 1,219 | 1,328 | 1,501 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 1,358 | 1,487 | 1,642 | 1,714 | 2,026 | |
Interest coverage | x | 13.1 | 19.3 | 43.6 | 94.5 | 85.3 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.2 | 1.1 | 1.1 | 1.3 | 1.2 | |
Return on assets | % | 5.9 | 5.6 | 10.7 | 11.2 | 13.4 | |
Return on equity | % | 6.9 | 7.1 | 14.0 | 14.2 | 17.8 | |
Return on capital | % | 9.3 | 8.9 | 18.4 | 20.3 | 23.5 | |
Exports to sales | % | 2.0 | 2.8 | 3.8 | 2.1 | 2.3 | |
Imports to sales | % | 3.0 | 3.0 | 2.8 | 1.3 | 0 | |
Exports (fob) | Rs m | 33 | 45 | 72 | 45 | 55 | |
Imports (cif) | Rs m | 51 | 47 | 52 | 27 | 0 | |
Fx inflow | Rs m | 33 | 45 | 72 | 45 | 55 | |
Fx outflow | Rs m | 53 | 51 | 52 | 27 | 41 | |
Net fx | Rs m | -20 | -6 | 21 | 18 | 14 |
JAGSON PHAR CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 309 | 119 | 282 | 69 | 467 | |
From Investments | Rs m | -8 | -111 | -23 | -258 | -577 | |
From Financial Activity | Rs m | -61 | -18 | -68 | -176 | -5 | |
Net Cashflow | Rs m | 240 | -10 | 191 | -364 | -115 |
Share Holding
Shareholding as on Dec 2023
|
Company Information
|
CHM: Harsha Raghavan | COMP SEC: Abhishek Joshi | YEAR OF INC: 1978 | BSE CODE: 507789 | FV (Rs): 5 | DIV YIELD (%): 1.6 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare JAGSON PHAR With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.